Manufacturer
Apotex Inc.-Richmond Hill Site
Contents
Deferiprone (L1)
Indication
Iron overload in patient w/ thalassaemia.
Instruction
May be taken with or without food. 25 mg/kg tid, may be adjusted according to response and therapeutic goals. Max: 100 mg/kg daily.
Drug interaction
Serum concentration may be increased by UGT1A6 inhibitors (e.g. phenylbutazone). May chelate polyvalent cations, allow at least 4-hr interval w/ antacids and mineral supplements containing Al, Fe or Zn. Risk of additive toxicity w/ drugs that may cause neutropenia or agranulocytosis
Malaysia
